Company Profile
Shanghai Huachu Industrial Co., Ltd. is a professional enterprise with core competence in high-end pharmaceutical intermediates. The R&D center is located in Shanghai fully equipped with advanced analytical instruments and organic synthesis plants, and has a total area of 3000- square meters laboratory including several kilo-labs in scale-up of synthesis technology. We have over 60 professional researchers, 80% of them have master degree or above, and rich experience and strength of R&D in custom synthesis, process development and research of impurities.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate |
D-erythro-Pentonic acid,2-deoxy-2,2-difluoro-,γ-lactone,3,5-dibenzoate;2-Deoxy-2,2-difluoro-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate;2-Deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate;1254301-18-2 |
122111-01-7 | - / 98% | Inquiry |
Abiraterone acetate |
Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-,acetate (ester),(3β)-;CB 7630;Abiraterone acetate;Zytiga;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-yl acetate;1643848-36-5 |
154229-18-2 | - / 99.50% | Inquiry |
Afatinib |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;Afatinib;BIBW 2992;Tovok;Gilotrif;Giotrif |
850140-72-6 | - / 99% | Inquiry |
Apixaban |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide;BMS 562247-01;Apixaban;Eliquis;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-47-3 | - / 99.00% | Inquiry |
Aprepitant |
3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-;3H-1,2,4-Triazol-3-one,5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,[2R-[2α(R*),3α]]-;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;L 754030;MK 869;Aprepitant;MK 0869;Emend;ONO 7436;221350-96-5 |
170729-80-3 | - / 99% | Inquiry |
Bevantolol hydrochloride |
2-Propanol,1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-,hydrochloride (1:1);2-Propanol,1-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-,hydrochloride;1-[(3,4-Dimethoxyphenethyl)amino]-3-(m-tolyloxy)-2-propanol hydrochloride;CI 775;Bevantolol hydrochloride;NC 1400;Ranestol;Cl 775;Vantol;Sentiloc;107751-99-5 |
42864-78-8 | - / 99.00% | Inquiry |
Blonanserin |
Cycloocta[b]pyridine,2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-;2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine;AD 5423;Blonanserin;Lonasen |
132810-10-7 | - / 99.00% | Inquiry |
Capecitabine |
Cytidine,5′-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Carbamic acid,[1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-,pentyl ester;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Ro 09-1978/000;Capecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Xeloda;Capecitibine;Capecytabine;Capiibine;Captabin;N4-Pentyloxycarbonyl-5′-deoxy-5-fluorocytidine;Capacetrine;Ecansya;Capecitabine Medac;Capecitabine Accord;Capecitabine Teva;Capecitabine SUN;Xeltabin;158798-73-3;958887-39-3 |
154361-50-9 | - / 99.5% | Inquiry |
Colesevelam |
1-Hexanaminium,N,N,N-trimethyl-6-(2-propen-1-ylamino)-,chloride (1:1),polymer with 2-(chloromethyl)oxirane,2-propen-1-amine and N-2-propen-1-yl-1-decanamine,hydrochloride;1-Hexanaminium,N,N,N-trimethyl-6-(2-propenylamino)-,chloride,polymer with (chloromethyl)oxirane,2-propen-1-amine and N-2-propenyl-1-decanamine,hydrochloride;Oxirane,(chloromethyl)-,polymer with 2-propen-1-amine,N-2-propenyl-1-decanamine and N,N,N-trimethyl-6-(2-propenylamino)-1-hexanaminium chloride,hydrochloride;2-Propen-1-amine,polymer with (chloromethyl)oxirane,N-2-propenyl-1-decanamine and N,N,N-trimethyl-6-(2-propenylamino)-1-hexanaminium chloride,hydrochloride;1-Decanamine,N-2-propenyl-,polymer with (chloromethyl)oxirane,2-propen-1-amine and N,N,N-trimethyl-6-(2-propenylamino)-1-hexanaminium chloride,hydrochloride;CholestaGel;Colesevelam hydrochloride;GT 31-104HB;GT 31-104;Welchol |
182815-44-7 | - / 99.90% | Inquiry |
Dabigatran etexilate mesylate |
β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester,methanesulfonate (1:1);β-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester,monomethanesulfonate;Pradaxa;BIBR 1048MS;Dabigatran etexilate mesylate;Dabigatran etexilate methanesulfonate;593282-20-3 |
872728-81-9 | - / 99.00% | Inquiry |
Desogestrel |
18,19-Dinorpregn-4-en-20-yn-17-ol,13-ethyl-11-methylene-,(17α)-;(17α)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol;17-Ethynyl-18-methyl-11-methyleneestr-4-en-17β-ol;Org 2969;13-Ethyl-11-methylene-18,19-dinor-17α-4-pregnen-20-yn-17-ol;Desogestrel;Cerazette;Dicromil;Cyclosa;Marvelon 150/320;(+)-Desogestrel;(+)-13β-Ethyl-17α-ethynyl-11-methylenegon-4-en-17β-ol |
54024-22-5 | - / 99.50% | Inquiry |
Dienogest |
19-Norpregna-4,9-diene-21-nitrile,17-hydroxy-3-oxo-,(17α)-;(17α)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile;STS 557;Dienogest;Dienogestril;17α-Cyanomethyl-17β-hydroxyestra-4,9-dien-3-one;Dinagest |
65928-58-7 | - / 99.50% | Inquiry |
Drospirenone |
Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2′(5′H)-furan]-3,5′(2H)-dione,1,3′,4′,6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-,(2′S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-;Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2′(5′H)-furan]-3,5′(2H)-dione,1,3′,4′,6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-,[6R-(6α,7α,8β,9α,10β,13β,14α,15α,16α,17β)]-;(2′S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-1,3′,4′,6,7,8,9,10,11,12,13,14,15,16,20,21-Hexadecahydro-10,13-dimethylspiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2′(5′H)-furan]-3,5′(2H)-dione;1,2-Dihydrospirorenone;Drospirenone;Dihydrospirorenone;ZK 30595;3-Oxo-6β,7β:15β,16β-dimethylene-17α-pregn-4-en-21,17-carbolactone;BRN 4765500;CCRIS 6523;Drospirenona;6β,7β:15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone;17β-Hydroxy-6β,7β:15β,16β-dimethylene-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone |
67392-87-4 | - / 99.50% | Inquiry |
Entecavir |
6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-;6H-Purin-6-one,2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,[1S-(1α,3α,4β)]-;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;BMS 200475;Entecavir;SQ 34676;Baraclude;ETV;31: PN: WO2016077321 SEQID: 31 claimed sequence |
142217-69-4 | - / 99.50% | Inquiry |
Fluorocytosine |
2(1H)-Pyrimidinone,6-amino-5-fluoro-;2(1H)-Pyrimidinone,4-amino-5-fluoro-;Cytosine,5-fluoro-;6-Amino-5-fluoro-2(1H)-pyrimidinone;5-Fluorocytosine;Flucytosine;4-Amino-5-fluoropyrimidin-2(1H)-one;5-Fluorocytosin;Flucytosin;Ro 2-9915;Fluocytosine;Ancobon;Fluorocytosine;Ancotyl;Ancotil;6-Amino-2-oxo-5-fluoropyrimidine;Alcobon;NSC 103805;4-Amino-5-fluoropyrimidin-2-ol;Toca FC |
2022-85-7 | - / 99.00% | Inquiry |
Flurbiprofen axetil |
[1,1′-Biphenyl]-4-acetic acid,2-fluoro-α-methyl-,1-(acetyloxy)ethyl ester;Flurbiprofen axetil;LFP 83;1-Acetoxyethyl 2-(2-fluoro-4-biphenylyl)propionate;Ropiopn;1-Acetoxyethyl 2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanoate |
91503-79-6 | - / 99.50% | Inquiry |
Gefarnate |
4,8,12-Tetradecatrienoic acid,5,9,13-trimethyl-,(2E)-3,7-dimethyl-2,6-octadien-1-yl ester,(4E,8E)-;4,8,12-Tetradecatrienoic acid,5,9,13-trimethyl-,3,7-dimethyl-2,6-octadienyl ester,(E,E,E)-;4,8,12-Tetradecatrienoic acid,5,9,13-trimethyl-,(2E)-3,7-dimethyl-2,6-octadienyl ester,(4E,8E)-;trans-3,7-Dimethyl-2,6-octadienyl 5,9,13-trimethyl-4,8,12-tetradecatrienoate;Gefarnate;5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester;Geranyl farnesylacetate;DA 688;Gefarnil;Gefarnyl;Gefanil;Alsanate;Dixnalate;Salanil;Gefulcer;Arsanyl;Zackal;Osteol;30462-47-6 |
51-77-4 | - / 99.00% | Inquiry |
Gefitinib |
4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;Iressa;Gefitinib;4-(3′-Chloro-4′-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline;(3-Chloro-4-fluorophenyl)[7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl]amine;4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline;ZD1839;Gefonib;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine |
184475-35-2 | - / 99.5% | Inquiry |
Gemcitabine Hydrochloride |
Cytidine,2′-deoxy-2′,2′-difluoro-,hydrochloride (1:1);Cytidine,2′-deoxy-2′,2′-difluoro-,monohydrochloride;LY 188011 hydrochloride;Gemcitabine hydrochloride;Gemzar;Gemsar;Gemcitera;GEMORAL;2′-Deoxy-2′,2′-difluorocytidine monohydrochloride |
122111-03-9 | - / 99% | Inquiry |
Gestodene |
18,19-Dinorpregna-4,15-dien-20-yn-3-one,13-ethyl-17-hydroxy-,(17α)-;(17α)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one;Gestodene;WL 70;SHB 331;Gestinol;110541-55-4 |
60282-87-3 | - / 99.50% | Inquiry |